Among @ European American participants enrolled in the Pharmacogenomic Evaluation of Antihypertensive Responses ( PEAR ) study and treated with atenolol for @ weeks , we prospectively followed a nested cohort that had both metabolomics profiling and genotype data available for the development of IFG .